LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,781,660 | -2.7% | 458,265 | 0.0% | 0.82% | +9.6% |
| Q2 2023 | $31,634,033 | +43.2% | 458,265 | 0.0% | 0.75% | +42.9% |
| Q1 2023 | $22,097,538 | -1.7% | 458,265 | +1.7% | 0.53% | -2.6% |
| Q4 2022 | $22,487,263 | +22.4% | 450,466 | 0.0% | 0.54% | +13.9% |
| Q3 2022 | $18,379,000 | -6.0% | 450,466 | +26.7% | 0.48% | -16.5% |
| Q2 2022 | $19,556,000 | +30.9% | 355,567 | -13.5% | 0.57% | +51.3% |
| Q1 2022 | $14,942,000 | -20.6% | 411,184 | +1.9% | 0.38% | -13.6% |
| Q4 2021 | $18,811,000 | +18.0% | 403,584 | +28.0% | 0.44% | +29.9% |
| Q3 2021 | $15,937,000 | +24.2% | 315,218 | +0.8% | 0.34% | +31.9% |
| Q2 2021 | $12,833,000 | +41.5% | 312,618 | 0.0% | 0.25% | +28.3% |
| Q1 2021 | $9,072,000 | +4.1% | 312,618 | +1.0% | 0.20% | +7.0% |
| Q4 2020 | $8,713,000 | +11.9% | 309,418 | +22.7% | 0.18% | -6.6% |
| Q3 2020 | $7,784,000 | -11.2% | 252,138 | +22.5% | 0.20% | -17.5% |
| Q2 2020 | $8,763,000 | – | 205,896 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |